Merck Gains FDA Approval for Novel Cardiovascular Pill as Kalshi Eyes Clinical Trial Bets

By Ed Silverman · STAT News · 2026-07-16

Merck Gains FDA Approval for Novel Cardiovascular Pill as Kalshi Eyes Clinical Trial Bets

STAT News reports that federal regulators have cleared Merck’s Lipfendra, a first-of-its-kind oral treatment designed to significantly lower LDL cholesterol in high-risk patients. Simultaneously, the prediction exchange Kalshi is moving into the life sciences sector by launching

STAT News reports that federal regulators have cleared Merck’s Lipfendra, a first-of-its-kind oral treatment designed to significantly lower LDL cholesterol in high-risk patients. Simultaneously, the prediction exchange Kalshi is moving into the life sciences sector by launching